ArticleCureus2025

A Comparative Study of Gemcitabine-Cisplatin vs. Dose-Dense MVAC (Methotrexate, Vinblastine, Doxorubicin, and Cisplatin) as Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Single-Institution Experience.

Varun Goel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.